05 Jan 2018
Update on UK and US facilities
Today’s update on Abzena’s new facilities in Cambridge and San Diego is in line with expectations. We continue to expect strong growth in non-licensing revenue (30% CAGR FY2017-20), propelled in particular by rapid expected growth in manufacturing-related income, coupled with increased operational efficiency as a result of the increasingly integrated nature of Abzena’s services and manufacturing offering. We reiterate our positive stance.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Update on UK and US facilities
Abzena (ABZA:LON) | 0 0 (-0.9%) | Mkt Cap: 54.0m
- Published:
05 Jan 2018 -
Author:
Jens Lindqvist -
Pages:
3
Today’s update on Abzena’s new facilities in Cambridge and San Diego is in line with expectations. We continue to expect strong growth in non-licensing revenue (30% CAGR FY2017-20), propelled in particular by rapid expected growth in manufacturing-related income, coupled with increased operational efficiency as a result of the increasingly integrated nature of Abzena’s services and manufacturing offering. We reiterate our positive stance.